ALLISON ERNEST: Open Payments
NPI 1235762964 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 18 payments from 10 companies in 2025. Trend: 2023 $1,264 · 2024 $939 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| Lundbeck LLC | 2 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 1 | $44 |
| ABBVIE INC. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: CAPLYTA, REXULTI, SPRAVATO, VRAYLAR, TRINTELLIX, Auvelity, COBENFY, ABILIFY MAINTENA.
Industry payments across VA — which companies pay providers there.
